Newman Ferrara LLP Announces Investigation of American Renal Associates Holdings, Inc.

By a News Reporter-Staff News Editor at Health & Medicine Week -- Newman Ferrara LLP has begun an investigation into whether the officers and directors of American Renal Associates Holdings, Inc. ("American Renal Associates") (NYSE:ARA) breached their fiduciary duties to the company (see also Newman Ferrara LLP).

According to a complaint filed in the United States District Court in Florida's Southern District by a health insurer, American Renal Associates engaged in a "fraudulent and illegal scheme" to extract higher reimbursement payments by convincing patients to sign up for health insurance, rather than remaining on Medicare and Medicaid, while indirectly paying premiums for those same patients. The suit seeks unspecified damages and injunctive relief.

Newman Ferrara's investigation concerns the extent to which certain American Renal Associates' officers and directors knew or should have known of the alleged "fraudulent and illegal scheme."

If you hold American Renal Associates' stock and wish to obtain additional information about the investigation and your legal rights and potential remedies, please contact Newman Ferrara attorney Roger Sachar Jr. at rsachar@nfllp.com.

Newman Ferrara maintains a multifaceted practice based in New York City with attorneys specializing in complex commercial and multi-party litigation, securities fraud and shareholder litigation, consumer protection, civil rights, and real estate. For more information, please visit the firm website at www.nfllp.com. View source version on businesswire.com: http://www.businesswire.com/news/home/20160712006524/en/

Keywords for this news article include: Kidney, Nephrology, Legal Issues, Newman Ferrara LLP.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2016, NewsRx LLC